FTADX | RERAX | FTADX / RERAX | |
Total Expense Ratio | 1.12 | 1.57 | 71% |
Annual Report Gross Expense Ratio | 1.12 | 1.57 | 71% |
Fund Existence | 21 years | 23 years | - |
Gain YTD | 18.434 | 12.433 | 148% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.3B | 134B | 8% |
Annual Yield % from dividends | 1.98 | 0.23 | 846% |
Returns for 1 year | 14.37 | 4.08 | 352% |
Returns for 3 years | 51.51 | 26.81 | 192% |
Returns for 5 years | 34.03 | 12.35 | 275% |
Returns for 10 years | 46.83 | 21.06 | 222% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPYC | 42.50 | 1.11 | +2.69% |
Simplify US Equity PLUS Convexity ETF | |||
JMOM | 64.62 | 0.66 | +1.03% |
JPMorgan US Momentum Factor ETF | |||
SPXX | 17.97 | 0.13 | +0.73% |
Nuveen S&P 500 Dynamic Overwrite Fund | |||
BBC | 20.32 | 0.13 | +0.65% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
EFFE | 21.87 | N/A | N/A |
Harbor Osmosis Emerging Markets Resource Efficient ETF |